Sarah Gheuens
Chief Tech/Sci/R&D Officer at AGIOS PHARMACEUTICALS, INC.
Net worth: 1 M $ as of 30/03/2024
Profile
Sarah Gheuens is currently the Director at Viridian Therapeutics, Inc. since 2023.
She is also the Chief Medical Officer and Head of Research & Development at Agios Pharmaceuticals, Inc. since 2019.
In terms of education, Dr. Gheuens holds a doctorate degree from Vrije Universiteit Brussel, a graduate degree from Harvard Medical School, and another doctorate degree from the University of Antwerp.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 04/03/2024 | 39,066 ( 0.07% ) | 1 M $ | 30/03/2024 | |
| 20/09/2023 | 0 ( -.--% ) | - $ | 30/03/2024 |
Sarah Gheuens active positions
| Companies | Position | Start |
|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 31/08/2021 |
| VIRIDIAN THERAPEUTICS, INC. | Director/Board Member | 24/09/2023 |
Training of Sarah Gheuens
| Vrije Universiteit Brussel | Doctorate Degree |
| Harvard Medical School | Graduate Degree |
| University of Antwerp | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| VIRIDIAN THERAPEUTICS, INC. | Health Technology |
- Stock Market
- Insiders
- Sarah Gheuens
